408 related articles for article (PubMed ID: 11423932)
1. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
2. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
3. Replication and packaging of helper-dependent adenoviral vectors.
Sato M; Suzuki S; Kubo S; Mitani K
Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
[TBL] [Abstract][Full Text] [Related]
4. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
[TBL] [Abstract][Full Text] [Related]
5. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
6. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
Parks R; Evelegh C; Graham F
Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM
Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194
[TBL] [Abstract][Full Text] [Related]
8. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
[TBL] [Abstract][Full Text] [Related]
9. Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency.
Yoshioka Y; Asavatanabodee R; Eto Y; Watanabe H; Morishige T; Yao X; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Life Sci; 2008 Nov; 83(21-22):747-55. PubMed ID: 18930744
[TBL] [Abstract][Full Text] [Related]
10. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
Allen JM; Halbert CL; Miller AD
Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
[TBL] [Abstract][Full Text] [Related]
11. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination.
Umaña P; Gerdes CA; Stone D; Davis JR; Ward D; Castro MG; Lowenstein PR
Nat Biotechnol; 2001 Jun; 19(6):582-5. PubMed ID: 11385466
[TBL] [Abstract][Full Text] [Related]
12. Human adenovirus type 35: nucleotide sequence and vector development.
Gao W; Robbins PD; Gambotto A
Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
[TBL] [Abstract][Full Text] [Related]
13. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
[TBL] [Abstract][Full Text] [Related]
14. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
[TBL] [Abstract][Full Text] [Related]
15. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
Zhou HS; Zhao T; Rao XM; Beaudet AL
J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
[TBL] [Abstract][Full Text] [Related]
16. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
[TBL] [Abstract][Full Text] [Related]
17. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
18. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
Zhou H; Beaudet AL
Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335
[TBL] [Abstract][Full Text] [Related]
19. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
[TBL] [Abstract][Full Text] [Related]
20. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]